Global Biosimilars Market Expands as Patent Expiries Accelerate Adoption

The biosimilars market has moved from being a niche segment of the pharmaceutical industry to a strategic pillar of global healthcare systems. As biologic drugs lose patent protection and healthcare budgets tighten, biosimilars are no longer viewed as “alternatives” but as essential tools for improving patient access and system sustainability.

This article presents a biosimilars: in-depth market analysis grounded in verifiable regulatory frameworks, real-world adoption trends, and credible industry insights. Drawing on publicly available information from regulators such as the FDA, EMA, and WHO, along with industry intelligence including Transpire Insight, the goal is to provide a clear, practical, and trustworthy view of where the biosimilars market stands today and where it is heading toward 2026.

Get More Info: https://www.transpireinsight.com/report/biosimilars-market